Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 11, 1996, Pages 3993-3997

  Papapoulos, Socrates E ^a   Frölich, Marijke ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; COLLAGEN TYPE 1; DEOXYPYRIDINOLINE; HYDROXYPROLINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; DRUG EFFICACY; DRUG EXCRETION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; OSTEOLYSIS; PAGET BONE DISEASE; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; URINALYSIS;

ADULT; AGED; AGED, 80 AND OVER; AMINO ACIDS; BONE RESORPTION; COLLAGEN; COLLAGEN TYPE I; DIPHOSPHONATES; FEMALE; HUMANS; HYDROXYPROLINE; MALE; MIDDLE AGED; OSTEITIS DEFORMANS; PEPTIDES; PROGNOSIS; TIME FACTORS;

EID: 0029821370     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.11.3993     Document Type: Article

References (27)

1. Bijvoet OLM, Vellenga CJLR, Harinck HIJ. 1989 Paget's disease of bone: assessment, therapy and secondary prevention. In: Kleerekoper M, Krane SM, eds. Clinical disorders of bone and mineral metabolism. New York: Liebert; 525-542.
2. Kanis JA. 1991 Pathophysiology and treatment of Paget's disease of bone. London: Dunitz.
3. Harinck HIJ, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OLM. 1987 Paget's disease of bone: early and late responses to three different modes of treatment with aminoxydroxypropylidene bisphosphonate (APD). Br Med J. 295:1301-1305.
4. Thiebaud D, Jaeger P, Gobelet C, Jacquet AF, Burckhaidt P. 1988 A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone. Am J Med. 85:207-212.
5. Schweitzer DH, Zwinderman AH, Vermeij P, Bijvoet OLM, Papapoulos SE. 1993 Improved treatment of Paget's disease with dimethylaminohydroxypropylidene bisphosphonate. J Bone Miner Res. 8:175-182.
6. Atkins RM, Yates AJP, Gray RES, et al. 1987 Aminohexane diphosphonate in the treatment of Paget's disease of bone. J Bone Miner Res. 2:273-279.
7. O'Dohery DP, Bickerstaff DR, McCloskey EV, et al. 1990 Treatment of Paget's disease of bone with aminohydroxybutylidene bisphosphonate. J Bone Miner Res. 5:483-491.
8. Kanis JA, McCloskey EV. 1990 The use of clodronate in disorders of calcium and skeletal metabolism. In: Kanis JA, ed. Calcium metabolism. Progress in basic and clinical pharmacology. Basel: Karger; vol 4:89-136.
9. Uebelhart D, Gineyts E, Chapuy MC, Delmas PD. 1990 Urinary excretion of pyridinium crosslinks: a new marker of bone resorption in metabolic bone diseases. Bone Miner. 8:87-96.
10. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ. 1991 Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Eur J Clin Invest. 21:310-315.
11. Hassager C, Colwell A, Assiri AMA, Eastell R, Russell RGG, Christiansen C. 1992 Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium crosslinks: a longitudinal and cross-sectional study. Clin Endocrinol (Oxf). 37:45-50.
12. Body JJ, Delmas PD. 1992 Urinary pyridinium cross-links as markers of bone resorption in tumor-associated hypercalcemia. J Clin Endocrinol Metab. 74:481-486.
13. Hanson DA, Weis MAE, Bollen A-M, Maslan SL, Singer FR, Eyre DR. 1992 A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res. 7:1251-1258.
14. Delmas PD, Gineyts E, Bertholin A, Garnero P, Marchand F. 1993 Immunoassay of pyridinoline crosslink excretion in normal adults and in Paget's disease. J Bone Miner Res. 8:643-648.
15. Garnero P, Gineyts E, Riou JP, Delmas PD. 1994 Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab. 79:780-785.
16. Gertz BJ, Shao P, Hanson DA, et al. 1994 Monitoring bone resorption in early postmenopausal women by an immunoassay for crosslinked collagen peptides in urine. J Bone Miner Res. 9:135-142.
17. Hamdy NAT, Papapoulos SE, Colwell A, Eastell R, Russell RGG. 1993 Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone? Bone Miner. 22:1-8.
18. van der Pluijm G, Binderup L, Bramm E, et al. 1992 Disodium 1-hydroxy-3-(1-pyrrolidinyl)-propylidene-1,1-bisphosphonate (EB-1053) is a potent inhibitor of bone resorption in vitro and in vivo. J Bone Miner Res. 7:775-781.
19. Boonekamp PM, Löwik CWGM, van der Wee-Pals LJA, van Wijk-van Leenep MML, Bijvoet OLM. 1987 Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group. Bone Miner. 2:29-42.
20. Papapoulos SE, Hoekman K, Löwik CWGM, Vermeij P, Bijvoet OLM. 1989 Application of an in vitro model and a clinical protocol in the assessment of the potency of a new bisphsphonate. J Bone Miner Res. 4:775-781.
21. Prockop DJ, Udenfriend S. 1960 A specific method for the analysis of hydroxyproline in tissue and urine. Anal Biochem. 1:228-239.
22. Harinck HIJ, Bijvoet OLM, Blanksma HJ, Dahlinghaus-Nienhuis AJ. 1987 Efficacious management with aminobisphosphonate (APD) in Paget's disease of bone. Clin Orthop. 217:79-98.
23. Rosen HN, Dresner-Pollak R, Moses AC, et al. 1994 Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as markers of bone turover in humans. Calcif Tissue Int. 54:26-29.
24. Papapoulos SE. 1995 Pharmacodynamics of bisphosphonates in man: Implications for treatment. In: Bijvoet OLM, Fleisch H, Canfield RE, Russell RGG, eds. Bisphosphonate on bones. Amsterdam: Elsevier; 231-245.
25. Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. 1994 Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab. 79:1693-1700.
26. Prestwood KM, Pilbeam CC, Burleson JA, et al. 1994 The short term effects of conjugated estrogen on bone turnover in older women. J Clin Endocrinol Metab. 79:366-371.
27. Deacon AD, Hulme P, Hesp R, Green JR, Tellez M, Reeve J. 1987 Estimation of whole body resorption rate: a comparison of urinary hydroxyproline excretion with two radioisotopic tracer methods in osteoporosis. Clin Chim Acta. 166:297-306.